Cargando…
Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma
Background: Metastatic melanoma has poor therapeutic response and may present resistance to chemotherapy or immunotherapy. Significant differences are observed in the survival time of patients with metastatic melanoma based on the administration of chemotherapy or immunotherapy; thus, we have explor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580330/ https://www.ncbi.nlm.nih.gov/pubmed/34675134 http://dx.doi.org/10.18632/aging.203640 |